[1]
J. Giuliani and M. Marzola, “Case 2 – Trabectedin as a new opportunity in the multidisciplinary approach to the advanced ovarian cancer: report of a long-term survival case:  ”, CBN, vol. 1, no. 1, pp. 25–28, Oct. 2013.